Chromosomal imbalances in choroid plexus tumors

被引:64
作者
Rickert, CH
Wiestler, OD
Paulus, W
机构
[1] Univ Hosp Munster, Inst Neuropathol, D-48129 Munster, Germany
[2] Univ Hosp Bonn, Inst Neuropathol, Bonn, Germany
关键词
D O I
10.1016/S0002-9440(10)64931-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We studied 49 choroid plexus tumors by comparative genomic hybridization. Chromosomal imbalances were found in 32 of 34 choroid plexus papillomas and 15 of 15 choroid plexus carcinomas. Choroid plexus papillomas frequently showed +7q (65%), +5q (62%), +7p (59%), +5p (56%), +9p (50%, +9q (41%), +12p, +12q (38%), and +8q (35%) as well as -10q (56%), -10p, and -22q (47%); choroid plexus carcinomas mainly showed +12p, +12q, +20p (60%, +1, +4q, +20q (53%, +4p (47%), +8q, +14q (40%), +7q, +9p, +21 (33%) as well as -22q (73%), -5q (40%), -5p, and -18q (33%). Several chromosomal imbalance differences could he found that were characteristic for a tumor entity or age group. In choroid plexus papillomas +5q, +6q, +7q, +9q, +15q, +18q, and -21q were significantly more common whereas choroid plexus carcinomas were characterized by +1, +4q, +10, +14q, +20q, +21q, -5q, -9p, -11, -15q, and -18q. Among choroid plexus papillomas, children more often showed +8q, +14q, +12, and +20q; adults mainly presented with +5q, +6q, +15q, +18q, and -22q. Although the number of aberrations overall as well as of gains and losses on their own bore no significance on survival among choroid plexus tumors, a significantly longer survival among patients with choroid plexus carcinomas was associated with +9p and -10q. Our results show that aberrations differ between choroid plexus papillomas and choroid plexus carcinomas as well as between pediatric and adult choroid plexus papillomas, supporting the notion of different genetic pathways. Furthermore, gain of 9p and loss of 10q seem to be correlated with a more favorable prognosis in choroid plexus carcinomas.
引用
收藏
页码:1105 / 1113
页数:9
相关论文
共 42 条
[11]   CHROMOSOME-ABNORMALITIES IN LOW-GRADE CENTRAL-NERVOUS-SYSTEM TUMORS [J].
GRIFFIN, CA ;
LONG, PP ;
CARSON, BS ;
BREM, H .
CANCER GENETICS AND CYTOGENETICS, 1992, 60 (01) :67-73
[12]  
Kato T, 1996, Noshuyo Byori, V13, P99
[13]  
Kleihues P, 1997, AM J PATHOL, V150, P1
[14]  
Kraus JA, 2001, ACTA NEUROPATHOL, V102, P69
[15]   Endoreduplication and telomeric association in a choroid plexus carcinoma [J].
Li, YS ;
Fan, YS ;
Armstrong, RF .
CANCER GENETICS AND CYTOGENETICS, 1996, 87 (01) :7-10
[16]   RECURRENT CHROMOSOMAL IMBALANCES IN CHOROID-PLEXUS TUMORS [J].
MERTENS, F ;
HEIM, S ;
MANDAHL, N ;
MITELMAN, F ;
BRUN, A ;
STROMBLAD, LG ;
KULLENDORFF, CM ;
DONNER, M .
CANCER GENETICS AND CYTOGENETICS, 1995, 80 (01) :83-84
[17]   DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours [J].
Mollenhauer, J ;
Wiemann, S ;
Scheurlen, W ;
Korn, B ;
Hayashi, Y ;
Wilgenbus, KK ;
vonDeimling, A ;
Poustka, A .
NATURE GENETICS, 1997, 17 (01) :32-39
[18]   CYTOGENETIC ANALYSIS OF 109 PEDIATRIC CENTRAL-NERVOUS-SYSTEM TUMORS [J].
NEUMANN, E ;
KALOUSEK, DK ;
NORMAN, MG ;
STEINBOK, P ;
COCHRANE, DD ;
GODDARD, K .
CANCER GENETICS AND CYTOGENETICS, 1993, 71 (01) :40-49
[19]  
Nishizaki T, 1998, GENE CHROMOSOME CANC, V21, P340, DOI 10.1002/(SICI)1098-2264(199804)21:4<340::AID-GCC8>3.0.CO
[20]  
2-Z